| IMGT/mAb-DB ID | 313 |
|---|
| INN (International Nonproprietary Name) | detumomab |
|---|---|
| INN number | 7156 |
| INN proposed list | 70 () |
| INN recommended list | 34 () |
| Common name | SPECIFID |
| Proprietary name |
| IMGT receptor type | IG |
|---|---|
| Species | Mus musculus |
| Conjugated/ Radiolabelled | |
| Origin clone species | |
| Origin clone name | |
| IMGT/2Dstructure-DB | |
| IMGT/3Dstructure-DB |
| Specificity target name [species] | |
|---|---|
| Development technology | |
| Biosimilars |
| Clinical indication | Cancers |
|---|---|
| Clinical domain | Oncology |
| Application | |
| Expression system | |
| Company | Unknown |
| Development status | |
| Regulatory agency status and year |
| Clinical Trials | 20 studies found, 3 recruiting |
|---|---|
| FDA / EMA / NCI number or ATC code |